The Technical Analyst
Integrity Applications, [IGAP]
Exchange: PNK Industry: Medical Instruments & Supplies
Integrity Applications, Price, Forecast, Insider, Ratings, Fundamentals & Signals
2.86% $3.24
America/New_York / 14 mar 2022 @ 00:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 50.23 mill |
| EPS: | -0.308 |
| P/E: | -10.52 |
| Earnings Date: | N/A |
| SharesOutstanding: | 15.50 mill |
| Avg Daily Volume: | 0.0059 mill |
| RATING 2022-08-04 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Neutral | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | ||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -10.52 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -10.52 | industry: PE -6.22 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 2.94 - 3.54 ( +/- 9.29%) |
| ATR Model: 14 days |
Forecast:
01:40 - $3.40
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $3.24 (2.86% ) |
| Volume | 0.0005 mill |
| Avg. Vol. | 0.0059 mill |
| % of Avg. Vol | 8.42 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For IGAP
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
IGAP
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Europe and the Asia Pacific. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
Latest Press Releases
2021-08-12 09:15:00 - Press Release
Integrity Applications, Inc. Implements Reverse Stock Split To Meet Nasdaq Initial Listing Requirements
Wilmington, de and ashdod, israel, aug. 12, 2021 (globe newswire) -- integrity applications, inc. (www.integrity-app.com) (otcqb: igap), innovator of glucotrack ®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and prediabetes, announced today that it has implemented a 1-for-13 reverse split of its issued and outstanding shares of common stock, to be effective prior to the opening of the market on friday, august 13, 2021.
2021-04-21 10:05:00 - Press Release
Integrity Applications Announces The Appointment Of David C. Klonoff, Md As Chair Of Scientific Advisory Board
Wilmington, de and ashdod, israel, april 21, 2021 (globe newswire) -- integrity applications, inc. (www.integrity-app.com) (otcqb: igap), innovator of glucotrack ® , a non-invasive device for measuring glucose levels in people with type 2 diabetes and prediabetes, announced today that it has appointed david c. klonoff, md as chair of the company's scientific advisory board.
2021-02-18 09:30:00 - Press Release
Integrity Applications Issues Shareholder Update Letter
Wilmington, de and ashdod, israel, feb. 18, 2021 (globe newswire) -- integrity applications, inc. (www.integrity-app.com) (igap), innovator of glucotrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and prediabetes, issued a letter to its shareholders providing an update on its business.
Latest News
2021-08-12 09:15:00 - GlobeNewsWire
Integrity Applications, Inc. Implements Reverse Stock Split To Meet NASDAQ Initial Listing Requirements
Wilmington, DE and Ashdod, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack ®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today that it has implemented a 1-for-13 reverse split of its issued and outstanding shares of common stock, to be effective prior to the opening of the market on Friday, August 13, 2021.
2021-04-21 10:05:00 - GlobeNewsWire
Integrity Applications Announces the Appointment of David C. Klonoff, MD as Chair of Scientific Advisory Board
Wilmington, DE and Ashdod, Israel, April 21, 2021 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack ® , a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today that it has appointed David C. Klonoff, MD as Chair of the Company's Scientific Advisory Board.
2021-02-18 09:30:00 - GlobeNewsWire
Integrity Applications Issues Shareholder Update Letter
Wilmington, DE and Ashdod, Israel, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, issued a letter to its shareholders providing an update on its business.